NASDAQ: CDTConduit Pharmaceuticals Inc Stock Ownership - Who owns Conduit Pharmaceuticals?
Insider buying vs selling
Have Conduit Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew Regan | Chief Executive Officer | 2025-06-03 | 154,799 | $3.23 | $500.00kBuy |
| Faith L. Charles | Director | 2025-04-16 | 115,194 | $0.87 | $99.99kBuy |
| Chele Chiavacci Farley | Director | 2025-03-30 | 32,022 | $0.89 | $28.50kBuy |
| Simon Jeremy Fry | Director | 2025-03-30 | 29,354 | $0.89 | $26.13kBuy |
| Freda C. Lewishall | Director | 2025-03-30 | 47,612 | $0.89 | $42.37kBuy |
| Faith L. Charles | Director | 2025-03-30 | 46,629 | $0.89 | $41.50kBuy |
| Freda C. Lewishall | Director | 2024-11-18 | 437,976 | $0.09 | $40.29kBuy |
| Faith L. Charles | Director | 2024-11-18 | 266,594 | $0.09 | $24.53kBuy |
| Chele Chiavacci Farley | Director | 2024-11-18 | 299,238 | $0.09 | $27.53kBuy |
| Nirland Ltd | 10% Owner | 2024-10-07 | 939,009 | $0.10 | $96.72kSell |
CDT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CDT insiders and whales buy or sell their stock.
CDT Shareholders
What type of owners hold Conduit Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Andrew Regan | 1,486.84% | 45,527,311 | $76.49M | Insider |
| Nirland Ltd | 198.95% | 6,092,000 | $10.23M | Insider |
| Jack Kendrick Heilbron | 155.75% | 4,769,250 | $8.01M | Insider |
| David Tapolczay | 65.42% | 2,003,324 | $3.37M | Insider |
| Sarborg Ltd | 60.55% | 1,853,933 | $3.11M | Insider |
| Murphy Canyon Acquisition Sponsor LLC | 24.62% | 754,000 | $1.27M | Insider |
| Shaolin Capital Management LLC | 20.15% | 616,950 | $1.04M | Insider |
| Freda C. Lewishall | 18.75% | 574,147 | $964.57k | Insider |
| Faith L. Charles | 5.40% | 165,238 | $277.60k | Insider |
| James Bligh | 1.22% | 37,272 | $62.62k | Insider |
CDT vs Biotech Stocks
Conduit Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.